loader image
Saturday, December 13, 2025
82.3 F
McAllen
- Advertisement -

Many Patients Receive Too Little Rehab Following a Stroke

Hispanic patients also received disproportionately lower amounts of rehab

Translate to Spanish or other 102 languages!

Many patients tracked in this study did not receive any rehabilitation therapy after their stroke. After three months, about one-third of patients had not received physical therapy, almost half had not received occupational therapy, and over 6 in 10 did not receive speech therapy. Image for illustration purposes
Many patients tracked in this study did not receive any rehabilitation therapy after their stroke. After three months, about one-third of patients had not received physical therapy, almost half had not received occupational therapy, and over 6 in 10 did not receive speech therapy. Image for illustration purposes

Mega Doctor News

- Advertisement -

By University of California, Los Angeles (UCLA), Health Sciences

Newswise — Many patients don’t receive much rehabilitation therapy following a stroke, despite strong evidence that higher amounts can reduce long-term disability, according to a new UCLA-led study that tracked over 500 patients across 28 acute care hospitals in their first year following a stroke.

The new research, published in the peer-reviewed journal Stroke, is the first U.S.-wide study to find that patients who had more severe strokes received higher amounts of rehabilitation therapy, a welcome finding. “But in the bigger picture, the findings reinforce that too many patients are missing out on a golden opportunity to maximize recovery during a critical period following a stroke,” said the study’s lead author, Steven Cramer, MD. Stroke is a leading cause of long-term disability in the United States and can affect speech, memory, and mobility, among other impairments.

- Advertisement -

“In the initial weeks after a stroke, the brain is ready to undergo maximum rewiring to get people back on their feet. Rehab therapy helps maximize this recovery, with higher rehab therapy doses helping more, but what we found in this study is that most patients are getting rather small doses of rehab therapy,” said Dr. Cramer, a stroke neurologist and professor of neurology at the David Geffen School of Medicine at UCLA and the California Rehabilitation Institute.

Among the study’s key findings:

–Many patients tracked in this study did not receive any rehabilitation therapy after their stroke. After three months, about one-third of patients had not received physical therapy, almost half had not received occupational therapy, and over 6 in 10 did not receive speech therapy.

–Those who did receive rehabilitation therapy typically had six to eight sessions by three months after their stroke – and between 0 and 1.5 sessions the rest of the year.

- Advertisement -

–Where patients were sent following hospitalization also mattered. Those who were discharged home had the lowest levels of rehabilitation therapy, regardless of the severity of their stroke.

–Hispanic patients received disproportionately lower amounts of physical therapy and occupational therapy.

Cramer said it is important for future research to examine the feasibility of providing higher therapy doses to stroke patients.

The other study authors are Brittany Young, MD, PhD, of UCLA and the California Rehabilitation Institute, and Alison Holman, PhD, FNP, of the Sue and Bill Gross School of Nursing at UC-Irvine.

Journal Link: Stroke

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Tips to Tame the ‘Sunday Scaries’

Weekends only last so long, and if you start feeling anxious by Sunday, you're not alone.

Watercress A Nutrient-Dense Leafy Green

Watercress is a leafy green that naturally grows in clean, slow-moving water and belongs to the same plant family as mustard greens, kale, and cabbage. It has a mild, peppery taste and can be eaten raw or cooked in many different meals.

Off-the-Shelf Immunotherapy Offers Hope for Aggressive Myeloma

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. 

FDA Approves Zenflow Spring® System for BPH Treatment

 Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as enlarged prostate.
- Advertisement -
×